Top section
Top section
Shipping company’s “amazingly well received” Greek offering draws €656m of demand
Africa’s largest IPO backed by Africa-focused Pan-African Refinery Investment after agreeing to $1bn underwriting programme
◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
More articles
More articles
More articles
-
Investors have got a fever, and the only cure is more pharma. Biotech equity issuance is surging, in line with rising stock prices in the secondary market, as stock pickers pan for the company that will cure Covid-19, among other maladies. But this is more speculating than investing and many are going to catch a cold chasing around a risky sector that is starting to look a lot like the dot-com bubble. -
Richard Livingstone, the British billionaire property developer, sold Skr5.5bn ($616m) of shares in Swedish online gambling company Evolution Gaming in an overnight trade on Monday, to help mitigate the effect of Covid-19 on his property portfolio.
-
ADO Properties, the German real estate developer, concluded its €450m rights issue on Monday, with a high take-up from its shareholders.
-
Ant Group, the Chinese financial technology giant behind popular mobile payments app Alipay, has set in motion plans to go public through IPOs in Hong Kong and Shanghai, in what are set to be landmark deals for Asia's equity markets.
-
Premier Oil, the UK oil company, has signed sale and purchase agreements to buy BP assets in the North Sea in a deal that could total up to $565m, with an equity raise earmarked to provide the funds for an upfront payment.
-
Freeline Theraputics, the UK gene therapeutics company, has filed to list in the US on the Nasdaq exchange, continuing the trend of biotech companies seeking to raise capital in the equity capital markets.
Sub-sections
shared comment list
